Riluzole is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Quinn Pharmaceuticals, Llc. The primary component is Riluzole.
| Product ID | 69076-611_d58c2bdc-ee77-4976-833d-0eff4cf78b79 | 
| NDC | 69076-611 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Riluzole | 
| Generic Name | Riluzole | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2019-01-14 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA204430 | 
| Labeler Name | Quinn Pharmaceuticals, Llc | 
| Substance Name | RILUZOLE | 
| Active Ingredient Strength | 50 mg/1 | 
| Pharm Classes | Benzothiazole [EPC],Benzothiazoles [CS] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2019-01-14 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA204430 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2019-01-14 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| RILUZOLE | 50 mg/1 | 
| SPL SET ID: | d58c2bdc-ee77-4976-833d-0eff4cf78b79 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0378-4145 | Riluzole | riluzole | 
| 42291-775 | Riluzole | riluzole | 
| 60505-3285 | RILUZOLE | RILUZOLE | 
| 62756-538 | Riluzole | Riluzole | 
| 64980-191 | Riluzole | riluzole | 
| 67877-286 | Riluzole | Riluzole | 
| 68084-908 | RILUZOLE | RILUZOLE | 
| 68462-381 | riluzole | riluzole | 
| 69076-200 | Riluzole | riluzole | 
| 69076-611 | Riluzole | Riluzole | 
| 10094-350 | EXSERVAN | riluzole | 
| 70510-2201 | Exservan | riluzole | 
| 70510-2202 | Exservan | riluzole | 
| 70515-700 | Rilutek | riluzole | 
| 70726-0303 | TIGLUTIK | Riluzole |